Questionable History of Immediate-Type Hypersensitivity to Penicillin in Staphylococcal Endocarditis: Treatment Based on Skin-Test Results Versus Empirical Alternative Treatment--A Decision Analysis
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Approximately 10% of the population claim to be allergic to penicillins, but only approximately 10%-30% of these have IgE-mediated reactions to penicillin skin tests. Alternatives to penicillins may be less effective, more toxic, and more expensive. Therefore, we used decision analysis to calculate maximum expected utility and minimum cost for skin-testing or not skin-testing patients who have endocarditis due to Staphylococcus aureus that is susceptible to cloxacillin and who have a questionable history of immediate-type hypersensitivity to penicillin. We used known probabilities of intermediate outcomes, actual costs, and measured utilities and included one-way sensitivity analysis. Whether utility, cost, or average cost-utility was the outcome of interest, skin-testing was preferred to no skin-testing in most conditions. Patients who have endocarditis due to S. aureus that is susceptible to cloxacillin and who also have a questionable history of immediate-type hypersensitivity to penicillin should be skin-tested before starting antibiotic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Bulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Idsøe, O., GUTHE, T., Willcox, R. R., & WECK, A. L. D. (1968) · Europe PMC (PubMed Central) · Cited by 540
Wilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
KORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355
Sogn, D. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400170105020 · Cited by 337 · cited 4×
“In the “skin test” strategy, the patient is tested with major and minor determinants of penicillin according to a standard protocol [14].”
InfluentialWilson, W. R. (1995) · JAMA · doi:10.1001/jama.274.21.1706 · Cited by 288
Pichichero, M. E., & Pichichero, D. M. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70499-8 · Cited by 200
A Perspective on Penicillin Allergy
Lin, R. Y.-W. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.5.930 · Cited by 200
Bayer, A. S. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.3.313 · Cited by 148
Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination
Goetz, M. B., & Sayers, J. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/32.2.325 · Cited by 144
DiNubile, M. J. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00009 · Cited by 105
Unsuccessful Treatment of Staphylococcal Endocarditis With Cefazolin
Bryant, R. E. (1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03270330059022 · Cited by 86
Menichetti, F., Martino, P., Bucaneve, G., Gentile, G., D’Antonio, D., Liso, V., Ricci, P., Nosari, A., Buelli, M., & Carotenuto, M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2041 · Cited by 77
STAPHYLOCOCCUS AUREUS BACTEREMIA AND ENDOCARDITIS
Mortara, L. A., & Bayer, A. S. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30505-5 · Cited by 72
Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts.
Mortara, L. A., & Bayer, A. S. (1993) · PubMed · Cited by 55
Sogn, D. D. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90111-8 · Cited by 52
Infective endocarditis in the 1980s: Part 1. Aetiology and diagnosis
KING, K. B., & Harkness, J. (1986) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1986.tb112282.x · Cited by 22
The Role of Skin Testing for Penicillin Allergy
Redelmeier, D. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390200117022 · Cited by 21
Vancomycin failure in staphylococcal endocarditis
Jackson, M. A., & Hicks, R. A. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198708000-00011 · Cited by 18
Penicillin allergy: a practical approach to management.
Sussman, G., Davis, K., & Köhler, P. F. (1986) · PubMed · Cited by 17
The treatment of staphylococcal endocarditis
Eykyn, S. J. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.suppl_a.161 · Cited by 10
The treatment of endocarditis by vancomycin
Newsom, S. W. B. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.suppl_d.79 · Cited by 7
Infective endocarditis in the 1980s
KING, K. B., & Harkness, J. (1986) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1986.tb112318.x · Cited by 6
Analysis of Therapeutic Options in Patients Reporting a Penicillin or Cephalosporin Allergy
Logan, H., & Bayliff, C. D. (1997) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v50i5.2082 · Cited by 6
The use of beta-lactam antibiotics in the treatment of septicaemia and endocarditis.
WATANAKUNAKORN, C. (1984) · PubMed · Cited by 5
Research works printed but not linked: 6
- Watanakunakorn, 1984, Scandinavian journal of infectious diseases. Supplementum, 42, 110
- KORZENIOWSKI, 1982, Annals of Internal Medicine, 97, 496, 10.1059/0003-4819-97-4-496 · doi:10.1059/0003-4819-97-4-496
- Levine, 1991, Annals of Internal Medicine, 115, 674, 10.1059/0003-4819-115-9-674 · doi:10.1059/0003-4819-115-9-674
- Sussman, 1986, Canadian Medical Association Journal, 134, 1353
- Lin, 1992, Archives of Internal Medicine, 152, 930, 10.1001/archinte.1992.00400170020005 · doi:10.1001/archinte.1992.00400170020005 · Paper page
- 1997, The Canadian journal of hospital pharmacy, 50, 201
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Clinical Management of Staphylococcus aureus Bacteremia: A Review
Holland, T. L., Arnold, C., & Fowler, V. G. (2014) · JAMA · doi:10.1001/jama.2014.9743 · Cited by 449
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
Salkind, A. R., Cuddy, P. G., & Foxworth, J. W. (2001) · JAMA · doi:10.1001/jama.285.19.2498 · Cited by 261
Metadata
- Authors
- Dodek, P., & Phillips, P.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Dodek, P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-11-01
- Volume
- 29
- Issue
- 5
- Pages
- 1251-1256
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2112215465
- Cited by
- 45
- References
- 27
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2019: 2 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 2
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- penicillin allergy, immediate hypersensitivity, Staphylococcus aureus endocarditis, penicillin skin testing, cloxacillin, empirical antibiotic therapy, cost-utility analysis, IgE-mediated reactions
- MeSH terms
- Cloxacillin, Decision Support Techniques, Drug Hypersensitivity, Endocarditis, Bacterial, Humans, Hypersensitivity, Immediate, Penicillins, Skin Tests, Staphylococcal Infections, Vancomycin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.